1. Home
  2. TW vs NTRA Comparison

TW vs NTRA Comparison

Compare TW & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TW
  • NTRA
  • Stock Information
  • Founded
  • TW 1996
  • NTRA 2003
  • Country
  • TW United States
  • NTRA United States
  • Employees
  • TW N/A
  • NTRA N/A
  • Industry
  • TW Investment Bankers/Brokers/Service
  • NTRA Medical Specialities
  • Sector
  • TW Finance
  • NTRA Health Care
  • Exchange
  • TW Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • TW 26.7B
  • NTRA 21.7B
  • IPO Year
  • TW 2019
  • NTRA 2015
  • Fundamental
  • Price
  • TW $119.32
  • NTRA $167.55
  • Analyst Decision
  • TW Strong Buy
  • NTRA Strong Buy
  • Analyst Count
  • TW 11
  • NTRA 16
  • Target Price
  • TW $151.36
  • NTRA $193.50
  • AVG Volume (30 Days)
  • TW 1.4M
  • NTRA 1.1M
  • Earning Date
  • TW 10-29-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • TW 0.40%
  • NTRA N/A
  • EPS Growth
  • TW 28.18
  • NTRA N/A
  • EPS
  • TW 2.59
  • NTRA N/A
  • Revenue
  • TW $1,931,872,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • TW $23.02
  • NTRA $23.93
  • Revenue Next Year
  • TW $11.43
  • NTRA $15.60
  • P/E Ratio
  • TW $46.07
  • NTRA N/A
  • Revenue Growth
  • TW 28.05
  • NTRA 44.38
  • 52 Week Low
  • TW $112.10
  • NTRA $114.62
  • 52 Week High
  • TW $152.65
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • TW 30.14
  • NTRA 61.35
  • Support Level
  • TW $117.26
  • NTRA $164.83
  • Resistance Level
  • TW $127.12
  • NTRA $168.94
  • Average True Range (ATR)
  • TW 2.73
  • NTRA 4.52
  • MACD
  • TW -0.56
  • NTRA 0.19
  • Stochastic Oscillator
  • TW 14.95
  • NTRA 76.12

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: